Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
BACKGROUND: Enhancer of zeste 2 (EZH2) promotes prostate cancer progression. We hypothesized that increased EZH2 expression is associated with postradiotherapy metastatic disease recurrence, and may promote radioresistance. METHODS: EZH2 expression was investigated using immunohistochemistry in diag...
Үндсэн зохиолчид: | Wu, X, Scott, H, Carlsson, S, Sjoberg, D, Cerundolo, L, Lilja, H, Prevo, R, Rieunier, G, Macaulay, V, Higgins, G, Verrill, C, Lamb, A, Cunliffe, V, Bountra, C, Hamdy, F, Bryant, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Wiley
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
-н: Pirovano, G, зэрэг
Хэвлэсэн: (2017) -
EZH2 promotes proliferation and invasiveness of prostate cancer cells.
-н: Bryant, R, зэрэг
Хэвлэсэн: (2007) -
The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells.
-н: Bryant, R, зэрэг
Хэвлэсэн: (2008) -
The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
-н: Bryant, R, зэрэг
Хэвлэсэн: (2007) -
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
-н: Charlton, P, зэрэг
Хэвлэсэн: (2023)